Sandbox: manpreet kaur: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
* Tetracycline(500mg) | * Tetracycline(500mg) | ||
* Metronidazole(500mg) | * Metronidazole(500mg) | ||
| | |BID | ||
| | |||
| | QID | ||
QID | |||
TID or QID | |||
|14 | |||
|NO(a) | |||
|- | |- | ||
| | |Levofloxacin triple | ||
| | | | ||
* PPI(standard dose) | * PPI(standard dose) | ||
* | * Levofloxacin (500mg) | ||
* Amox(1gm) | |||
| | | | ||
| | | | ||
Revision as of 16:57, 27 October 2017
| Salvage therapies for Helicobacter pylori infection | ||||
|---|---|---|---|---|
| Regimen | Drugs(doses) | Dosing frequency | Duration(days) | FDA approval |
| Bismuth quadruple |
|
BID
QID QID TID or QID |
14 | NO(a) |
| Levofloxacin triple |
|
|||
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
References
- References should be cited for the material that you have put on your page. Type in {{reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
- For information on how to add references into your page, click here.